Sano blog | press

press MASLD liver disease

New study data shows a better way to find patients with liver disease and what it means for clinical trials

Finding patients who qualify for a clinical trial has always been one of the hardest parts of running one. In liver disease, particularly MASLD, it is especiall...

press patient recruitment liver disease

Precision liver study completes 1-year recruitment of nearly 1,000 participants using existing NHS data

Somerset, UK, 18th March 2026: Predictive Health Intelligence (PHI) and Sano Genetics today announced the completion of recruitment into the LiveWell study, wit...

press precision medicine rare disease

Partnering to unlock the next chapter in lupus research

We’re proud to share that Sano Genetics plays a key role in the newly announced Lupus Nexus Foundational Analyses, a groundbreaking initiative led by the Lupus ...

press precision medicine patient engagement

Lupus Research Alliance Launches the DREAM Knowledge-Exchange Platform to Accelerate Precision Medicine in Lupus

Today, the Lupus Research Alliance (LRA) launched the Data Repository, Exchange, and Analytics Platform (DREAM)—a pioneering knowledge-sharing platform dedicate...

press precision medicine

Sano Genetics named in Bloomberg UK’s Startups to Watch 2024

LONDON – 22 October 2024: Sano Genetics, the UK-based precision medicine company accelerating precision medicine clinical trials, has been named as one of Bloom...

press patient recruitment genetic testing

Inherited retinal disease: Mobile eye care partnership

A new partnership will bring together specialist eye care, genetic testing, and patient recruitment to advance both clinical research and care for people affect...

press precision medicine

Sano Genetics raises $11.4 million led by Plural to power precision medicine revolution with seamless trials

Sano Genetics is the only software platform tailored to running precision medicine clinical trials, leveraging AI to manage all aspects from design to patient r...

press genetic testing neurodegenerative disease

Introducing Light the Way [press release]

Families affected by ALS urged to join free program to uncover their genetic risk, contribute to research, and access new therapies Sano Genetics launches ‘Ligh...

press precision medicine rare disease

Sano Genetics raises $11M in funding to accelerate genetic disease research

Sano raises $11 million in Series A funding round led by MMC Ventures New funding will support the team to grow and further its mission to accelerate personalis...

press patient recruitment

Sano Genetics accelerates research into Long Covid after raising £2.5M ($3.2M) in seed funding

Sano Genetics supports personalised medicine research by increasing participation in clinical trials and guiding patients through the process Half of clinical t...

Clinical research blog